Management of protozoal diarrhoea in H1V disease

HIV Medicine

Volumn 1, Issue 4, 2000, Pages 194-199

  Miao, Y M ^a   Gazzard, B G ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AIDS RELATED COMPLEX; ANIMAL; ENTEROPATHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; ISOLATION AND PURIFICATION; PARASITOLOGY; PATHOPHYSIOLOGY; PROTOZOON; REVIEW; TREATMENT OUTCOME;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMAL; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV ENTEROPATHY; HUMAN; PROTOZOA; TREATMENT OUTCOME;

EID: 0034305094     PISSN: 14642662     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1293.2000.00028.x     Document Type: Article

References (51)

1. Crotty B, Smallwood RA. Investigating diarrhea in patients with acquired immunodeficiency syndrome. Gastroenterology 1996; 110: 296-310.
2. Sharpstone D, Gazzard B. Gastrointestinal manifestations of HIV infection. Lancet 1996; 348: 379-383.
3. Blanshard C, Jackson AM, Shanson DC, Francis N, Gazzard BG. Cryptosporidiosis in HIV-seropositive patients. Q J Med 1992; 85: 813-823.
4. Palella FJ Jr, Delaney KM, Moorman AC etal Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-860.
5. American Gastroenterological Association (AGA) Clinical Practice and Practice Economics Committee. AGA technical review on the evaluation and management of chronic diarrhoea. Gastroenterology 1999; 116: 1464-1486.
6. Blanshard C, Francis N, Gazzard BG. Investigation of chronic diarrhoea in acquired immunodeficiency syndrome. A prospective study of 155 patients. Gut 1996; 39: 824-832.
7. Anonymous. Cryptosporidium in water supplies: the second Badenoch report. Communicable disease report. CDR Weekly 1995; 5: 245-248.
8. Miao YM, Awad-El-Kariem FM, Franzen C etal. Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy. JAcquir Immune Deβc Syndr 2000; in press.
9. FlaniganT, Whalen C.Turner J etal. Cryptosporidium infection and CD4 counts. Ann Intern Med 1992; 116: 840-842.
10. Manabe YC, Clark DP, Moore RD etal. Cryptosporidiosis in patients with AIDS. Correlates of disease and survival, Clin Infect Dis 1998; 27: 536-542.
11. Lim SG, Menzies IS, Lee Ca, Johnson MA, Pounder RE. Intestinal permeability and function in patients with human immunodeficiency virus. Scand J Gastroenterol 1993; 28: 573-580.
12. Bjamson I, Sharpstone DR, Francis N etal. Intestinal inflammation, Heal structure and function in HIV. AIDS 1996; 10: 1385-1391.
13. Schneider T, Jahn HU, Schmidt W etal. Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in peripheral blood. Gut 1995; 37: 524-529.
14. Snijders F, Meenan J, Van Den Blink B, Van Deventer SJH, Ten Kate FJW. Duodenal intraepithelial and lamina propria T lymphocytes in human immunodeficiency virus-infected patients with and without diarrhoea. Scand J Gastroenterol 1996;31: 1176-1181.
15. MacDonald TT, Spencer J. Evidence that activated mucosal T-cells play a role in the pathogenesis of enteropathy in human small intestine. J Eip Med 1988; 167: 1341-1349.
16. Goodgame RW, Kimball K, Ou CN etal. Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. Gastroenterology 1995; 108: 1075-1082.
17. Schmidt W, Schneider l, Heise W etal. Mucosal abnormalities in microsporidiosis. AIDS 1997; 11: 1589-1594.
18. Hayes PJ, Miao YM, Gotch FM. Gazzard BG. Alterations in blood leucocyte adhesion molecule profiles in HIV-1 infection. Clin Erp Immunol 1999; 117:331-334.
19. Miao YM, Hayes PJ, Gotch FM, Gazzard BG. Lymphocyte migration to the gut in HIV infection and HAART. 6th Annual Conference of the British HIV Association [BHIVA]. Edinburgh. March 2000 (abstract P46).
20. Miao YM, Bjarnson I, Crane R, Hayes PJ, Gazzard BG. Normalization of intestinal permeability in AIDS following successful antiretroviral therapy. 6th Annual Conference of the British HIV Association [BHIVA]. Edinburgh. March 2000 (abstract 013).
21. Goodgame RW. Understanding intestinal spore-forming protozoa: cryptosporidia, microsporidia, isospora, and cyclospora. Ann Intern Med 1996; 124: 429-441.
22. Culshaw RJ, Bancroft GJ, McDonald V. Gut intraepithelial lymphocytes induce immunity against cryptosporidium infection through a mechanism involving gamma Interferon production. Infect Immun 1997; 65: 3074-3079.
23. Okhuysen PC, Robinson P, Lewis DE etal. Sequential expression of IL-15, Interferon gamma, and IL-4 in cryptosporidiosis patients during immune reconstitution with HAART. 7th Conference on Retroviruses and Opportunistic Infections. San Francisco. January 2000 (abstract 263).
24. Sharpstone D, Neild P, Crane R etal. Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea. Gut 1999; 45: 70-76.
25. Garcia LS, Bruckner DA, Brewer TC, Shimizu RY. Techniques for recovery and identification of cryptosporidium oocysts from stool specimens. J Clin Microbiol 1983; 18: 185-190.
26. Vavra J, Dahbiova R, Hollister WS, Canning EU. Staining of microsporidian spores by optical brighteners with remarks on the use of brighteners for the diagnosis of AIDS associated human microsporidiosis. Folia Parasitai 1993; 40: 267-272.
27. Ryan NJ, Sutherland G, Coughlan K etal. A new trichromeblue stain for detection of microsporidial species in urine, stool, and nasopharyngeal specimens. J Clin Microbiol 1993; 31: 3264-3269.
28. Miao YM, Awad-El-Kariem FM, Gibbons CL, Gazzard BG. Cryptosporidiosis: eradication or suppression with combination antiretroviral therapy. AIDS 1999; 13: 734-735.
29. Muller A, Stellermann K, Hartmann P, etal. A powerful DNA extraction method and PCR for detection of microsporidia in clinical stool specimens. Clin Diagn Lab Immunol 1999; 6: 243-246.
30. Weber R, Biyan RT, Bishop HS, Wahlquist SP, Sullivan JJ, Juranek DD. Threshold of detection of cryptosporidium oocysts in human stool specimens: evidence for low sensitivity of current diagnostic methods. J Clin Microbiol 1991; 29: 1323-1327.
31. Balabat AB, Jordan GW, Tang YJ, Suva J Jr. Detection of Cryptosporidium parvum DNA in human feces by nested PCR. JCtin Microbiol 1996; 34: 1769-1772.
32. Gazzard B. Weight loss and diarrhoea. In: Gazzard B, ed. Chelsea ft Westminster Hospital AIDS Care Handbook. London, Mediscript Ltd, 1999: 201-214.
33. Leder K, Ryan N, Spelman D, Crowe S. Microsporidial disease in HIV-infected patients: a report of 42 patients and review of the literature. Scand J Infect Dis 1998; 30: 331-338.
34. Weber R, Sauer B, Sprycher MA eraJ. Detection of Septata intestinalis in stool specimens, and coprodiagnostic monitoring of successful treatment with albendazole. Clin Infect Dis 1994; 19: 242-245.
35. Franzen C, Muller A. Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia. Clin Microbiol Rev 1999; 12: 243-285.
36. Ledergerber B, Telenti A, Egger M. Risk of HIV-related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study. BMJ 1999; 319: 23-24.
37. Neild PJ, Nelson MR. Management of HIV-related diarrhoea. IntJSTDAlDS 1997; 8: 286-297.
38. Korich DG, Mead JR, Madore MS, Sinclair NA, Sterling CR. Effects of ozone, chlorine dioxide, chlorine, and monochloramine on Cryptosporidium pan-urn oocyst viability. Appl Environ Microbiol 1990; 56: 1423-1428.
39. Romeu J, Miro JM, Sirera G et al. Efficacy of octreotide in the management of chronic diarrhoea in AIDS. AIDS 1991; 5: 1495-1499.
40. Blanshard C, Shanson DC Gazzard EG. Pilot studies of azithromycin, letrazuril and paromomycin in the treatment of cryptosporidiosis. IntJSTDAlDS 1997; 8: 124-129.
41. Coyle C, Kent M, Tanowitz HB, Wittner M, Weiss LM. TNP-470 is an effective antimicrosporidial agent J Infect Dis 1998; 177: 515-518.
42. Didier ES, Nasr M, Leblanc J, Bertucci DC, Phillips J, Didier PJ. Antimicrosporidial effects of the sequiterpenes, fumagillin, TNP-470, and eight ovalicin derivatives in vitro and in vivo. 7th Conférence on Rftroviruses and Opportunistic Infections. San Francisco. January-February 2000 (abstract 262).
43. Awad-El-Kariem FM. Does Cryptosporidium parvum have a clonal population structure? Parasitai Today 2000; 15: 502-504.
44. Nord J, Ma P, DUohn D, Tzipori S, Tacket CO. Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. AIDS 1990; 4: 581-584.
45. Sharpstone D, Rowbottom A, Francis N et al. Thalidomide: a novel therapy for microsporidiosis [published erratum appears in Gastroenterology 1997; 113: 1054]. Gastroenterology 1997; 112: 1823-1829.
46. Sharpstone DR, Rowbottom AW, Nelson MR, Lepper MW, Gazzard EG. Faecal tumour necrosis factor-alpha in individuals with HIV-related diarrhoea. AIDS 1996; 10: 989-994.
47. Pape JW, Verdier RI, Johnson WD Jr. Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 320: 1044-1047.
48. Pape JW, Verdier RI, Boncy M, Boncy J, Johnson WD Jr. Cyclospora infection in adults infected with HIV. Clinical manifestations, treatment and prophylaxis. Ann Intern Med 1994; 121: 654-657.
49. Trier JS, Moxey PC, Schimmel EM, Robles E. Chronic intestinal coccidiosis in man: intestinal morphology and response to treatment. Gastroenterology 1974; 66: 923-935.
50. Zanders JJ, Cunningham PH, Kelleher AD, etal. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia. J Infect Dis 1999; 180: 320-329.
51. Sharkey ME, Teo I, Greenough T etal. Persistence of episomal HIV-1 infection intermediates in patients on highly active antiretroviral therapy. Nature 2000; 6: 76-8152.